# Analytical and Clinical Performance Testing Plan

> **NCT03595501** · — · COMPLETED · sponsor: **Sight Diagnostics** · enrollment: 679 (actual)

## Conditions studied

- Hematology
- Hematologic Test

## Interventions

- **DEVICE:** Hematology Analyzer - OLO
- **DEVICE:** Hematology Analyzer - Predicate

## Key facts

- **NCT ID:** NCT03595501
- **Lead sponsor:** Sight Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2019-03-06
- **Final completion:** 2019-08-25
- **Target enrollment:** 679 (ACTUAL)
- **Last updated:** 2021-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03595501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03595501, "Analytical and Clinical Performance Testing Plan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03595501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*